Cargando…
Associations between P2RY12 gene polymorphisms and risks of clopidogrel resistance and adverse cardiovascular events after PCI in patients with acute coronary syndrome
Clopidogrel resistance in patients with acute coronary syndrome (ACS) is one of the key causes of recurrent cardiovascular disease (CVD) events after percutaneous coronary intervention (PCI). Clopidogrel targets the platelet membrane receptor P2RY12 to inhibit platelet aggregation via adenosine diph...
Autores principales: | Li, Miaonan, Wang, Hongju, Xuan, Ling, Shi, Xiaojun, Zhou, Tong, Zhang, Ningru, Huang, Yuli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5411211/ https://www.ncbi.nlm.nih.gov/pubmed/28383427 http://dx.doi.org/10.1097/MD.0000000000006553 |
Ejemplares similares
-
Influence of proton pump inhibitors on clinical outcomes in coronary heart disease patients receiving aspirin and clopidogrel: A meta-analysis
por: Hu, Wen, et al.
Publicado: (2018) -
The Personality and Psychological Stress Predict Major Adverse Cardiovascular Events in Patients With Coronary Heart Disease After Percutaneous Coronary Intervention for Five Years
por: Du, Jinling, et al.
Publicado: (2016) -
Efficacy of Clopidogrel and Clinical Outcome When Clopidogrel Is Coadministered With Atorvastatin and Lansoprazole: A Prospective, Randomized, Controlled Trial
por: Zhang, Jian-rong, et al.
Publicado: (2015) -
MTHFR C677T gene polymorphism and the severity of coronary lesions in acute coronary syndrome
por: Li, Miao-Nan, et al.
Publicado: (2017) -
Investigation of the interaction between proton pump inhibitors and clopidogrel using VerifyNow P2Y12 assay
por: Lin, Sheng-Feng, et al.
Publicado: (2020)